Please use this identifier to cite or link to this item:
logo share SHARE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE

Heterocyclic inhibitors of glycogen synthase kinase GSK-3

AuthorsWandosell, Francisco CSIC ORCID ; Martínez, Ana CSIC ORCID ; Pérez Martín, María Concepción; Dorronsoro Díaz, Isabel; Alonso Cascón, Mercedes; Castro, Ana CSIC ORCID; Moreno Muñoz, Francisco José
KeywordsInhibitors of GSK-3
Issue Date16-Mar-2006
AbstractCompounds of formula (II) where Ra, Rb, Y and X take various meanings are of use in the preparation of a pharmaceutical formulation, for example in the treatment of a disease in which GSK-3 is involved, including Alzheimer's disease or the non-dependent insulin diabetes mellitus, or hyperproliferative disease such as cancer, displasias or metaplasias of tissue, psoriasis, arterosclerosis or restenosis
DescriptionFiling Date: 2006-02-17
Appears in Collections:(CBM) Patentes

Files in This Item:
File Description SizeFormat
F.Wandosell_AU_2006_200668_A1.pdf936,73 kBAdobe PDFThumbnail
Show full item record
Review this work

Page view(s)

checked on May 17, 2022


checked on May 17, 2022

Google ScholarTM


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.